Table 3. Changes in liver function parameters between groups.
Parameters | Treatment group | Placebo group | ||
---|---|---|---|---|
Baseline | Day 90 | Baseline | Day 90 | |
Bilirubin total | 0.97 ± 0.33 | 0.88 ± 0.17 | 1.05 ± 0.41 | 0.92 ± 0.18 |
Bilirubin direct | 0.34 ± 0.25 | 0.28 ± 0.10 | 0.37 ± 0.23 | 0.28 ± 0.11 |
Bilirubin indirect | 0.63 ± 0.19 | 0.60 ± 0.12 | 0.68 ± 0.25 | 0.65 ± 0.12 |
SGOT | 40.97 ± 23.47 | 33.68 ± 12.15 | 41.52 ± 28.00 | 32.03 ± 8.60 |
SGPT | 33.87 ± 20.59 | 32.52 ± 17.82 | 34.49 ± 23.57 | 32.66 ± 12.18 |
Alkaline phosphatase | 81.81 ± 22.93 | 84.42 ± 25.64 | 77.83 ± 17.72 | 84.59 ± 21.57 |
Total proteins | 7.53 ± 3.11 | 7.11 ± 0.54 | 7.29 ± 0.80 | 7.09 ± 0.51 |
Serum albumin (A) | 4.24 ± 0.44 | 4.06 ± 0.41 | 4.13 ± 0.39 | 4.03 ± 0.41 |
Serum globulin (G) | 3.36 ± 1.67 | 3.04 ± 0.26 | 3.16 ± 0.51 | 3.08 ± 0.26 |
Serum A/G ratio | 1.35 ± 0.61 | 1.31 ± 0.17 | 1.31 ± 0.18 | 1.28 ± 0.15 |
Data analyzed by Student’s t-test. Not significant at p < 0.05.